Reduced secretion of proinflammatory cytokines of monosodium urate crystal‐stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
- 1 May 2000
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 15 (5) , 644-649
- https://doi.org/10.1093/ndt/15.5.644
Abstract
In gouty arthritis, monosodium urate (MSU) crystals interact with monocytes and neutrophils to produce inflammatory reactions associated with acute synovitis. In patients with end-stage renal disease (ESRD), gouty arthritis is a rare condition despite often severe hyperuricaemia. We wondered whether differences in the secretion of proinflammatory cytokines by MSU crystal-stimulated monocytes might be one explanation for the low incidence of gouty arthritis in patients with ESRD compared with healthy controls. Thirteen patients with ESRD on intermittent haemodialysis treatment, six patients with chronic renal failure not yet on dialysis, and 15 age- and sex-matched healthy controls were examined. Monocytes, purified from peripheral blood mononuclear cells (PBMC) by immunomagnetic bead separation, were incubated for 18 h in the presence of MSU crystals, Escherichia coli lipopolysaccharide (LPS) or medium alone. The supernatants were studied for the presence of interleukin (IL)-1beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) using cytokine-specific enzyme-linked immunosorbent assays. Monocytes from patients with ESRD produced significantly lower amounts of IL-1beta, IL-6 and TNF-alpha after stimulation with MSU crystals or LPS than did monocytes from healthy subjects. Cytokine production was not significantly different between ESRD patients on haemodialysis and chronic renal failure patients not yet on dialysis. Artificial MSU crystals were stronger stimuli than tophus-derived 'natural' MSU crystals. We demonstrate that monocyte-associated immunosuppression in ESRD leads to reduced secretion of proinflammatory cytokines in response to stimuli such as MSU crystals. This may be one of the factors preventing many ESRD patients from the manifestation of acute gout despite often severe hyperuricaemia.Keywords
This publication has 21 references indexed in Scilit:
- Endothelial activation in monosodium urate monohydrate crystal‐induced inflammation. In vitro and in vivo studies on the roles of tumor necrosis factor α and interleukin‐1Arthritis & Rheumatism, 1997
- Inhibition and prevention of monosodium urate monohydrate crystal–induced acute inflammation in vivo by transforming growth factor β1Arthritis & Rheumatism, 1996
- Gouty arthritis and uric acid metabolismCurrent Opinion in Rheumatology, 1996
- Crystallographic antibodiesNature, 1995
- Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch modelArthritis & Rheumatism, 1993
- T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathwayKidney International, 1993
- Gout and mechanisms of crystal-induced inflammationCurrent Opinion in Rheumatology, 1993
- Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.Journal of Clinical Investigation, 1989
- Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.Journal of Clinical Investigation, 1987
- The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal DiseaseNew England Journal of Medicine, 1983